Interstitial preoperative high-dose-rate brachytherapy for early stage cervical cancer: Dose-volume histogram parameters, pathologic response and early clinical outcome

Preoperative HDRB for high-risk ESCCs represents a well-tolerated procedure, which leads to a high rate of postoperative pathologic response. Dose-volume histogram parameters were at least equivalent to those obtained with a low-dose-rate procedure. Long-term results will help to analyze the place of preoperative brachytherapy in the management of high-risk ESCCs.